Chemoprevention Trial in Familial Adenomatous Polyposis (FAP) Coli Using EPA

Clinical trial NCT00510692 · COMPLETED

Trial details

NCT number: NCT00510692
Sponsor: S.L.A. Pharma AG
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Familial Adenomatous Polyposis Coli FAP

Start date: 2006-11-01
Primary completion: 2008-04-01
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.